Inova and the FNIH Biomarkers Consortium Launch Public-Private Partnership to Develop Novel Imaging Methods to More Accurately Measure Cancer Response and Progression

inova logo

FALLS CHURCH, VA – Inova, in coordination with the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium, is launching a three-year research partnership to develop new methods for analyzing digital images that track a patient’s response to cancer therapy. Michael Maitland, MD, PhD, Director of Therapeutics for the Inova Center for Personalized Health…

Read More